𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Conditional relative survival in head and neck squamous cell carcinoma: Permanent excess mortality risk for long-term survivors

✍ Scribed by Marc P. van der Schroeff; Saskia A. M. van de Schans; Jay F. Piccirillo; Ton P. M. Langeveld; Robert J. Baatenburg de Jong; Maryska L. G. Janssen-Heijnen


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
249 KB
Volume
32
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background.

Dynamic predictions on head and neck cancer survival could offer, besides improved patient counseling, insight into long‐term effects of tumor‐ and patient‐based characteristics on survival. Theoretically, there could be a certain time period after diagnosis after which the patient returns to a population risk on survival.

Methods.

In all, 7255 patients with a primary head and neck squamous cell carcinoma (HNSCC) aged 25 to 90 years, diagnosed between January 1980 and January 2004 in The Netherlands, were included. Conditional 5‐year relative survival for every additional year survived was computed.

Results.

The overall conditional relative prognosis reached a plateau after approximately 4 years; a permanent 20% to 25% excess mortality for long‐term HNSCC survivors remained.

Conclusions.

Conditional 5‐year relative survival for patients with HNSCC remains poorer compared to age‐ and sex‐matched counterparts in the general population, even when alive at 15 years after diagnosis. We assume that this is caused by an excess comorbidity in these patients, mainly due to smoking and alcohol abuse. © 2010 Wiley Periodicals, Inc. Head Neck, 2010


📜 SIMILAR VOLUMES


Postoperative accelerated radiotherapy i
✍ Andy Trotti; Douglas Klotch; James Endicott; Marion Ridley; Alan Cantor 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

## Background: For patients treated with combination resection and postoperative radiotherapy, the interval between surgery and completion of radiotherapy represents an opportunity for tumor repopulation and treatment failure. a prospective trial to test the feasibility and efficacy of accelerated